awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37553978-30013E21-B606-478B-9989-AA229149E7A2
Q37553978-30013E21-B606-478B-9989-AA229149E7A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37553978-30013E21-B606-478B-9989-AA229149E7A2
Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management.
P2860
Q37553978-30013E21-B606-478B-9989-AA229149E7A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37553978-30013E21-B606-478B-9989-AA229149E7A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eac87e89268ecf29b7c147fcfe6419676e43041a
P2860
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.